ACT 101 Human Safety in Clinical Research

Pharmaceutical companies must pay close attention to the safety of human subjects at every stage of drug development, as explained in this QA view of the policies and regulations that make the system work.

Related Content:

Applied Clinical Trials-07-01-2001

Letters to the Editor

Conference Reports

Affairs of State